Your selection basket is empty.
Define a selection of ETFs which you would like to compare.
Add an ETF by clicking "Compare" on an ETF profile or by checkmarking an ETF in the ETF search.
| Index | Capital Strength |
| Investment focus | Equity, United States, Fundamental/Quality |
| Fund size | EUR 6 m |
| Total expense ratio | 0.60% p.a. |
| Replication | Physical (Full replication) |
| Legal structure | ETF |
| Investment approach | Long-only |
| Sustainability | No |
| Fund currency | USD |
| Currency risk | Currency unhedged |
| Volatility 1 year (in EUR) | 11.61% |
| Inception/ Listing Date | 27 January 2020 |
| Distribution policy | Accumulating |
| Distribution frequency | - |
| Fund domicile | Ireland |
| Fund Provider | First Trust |
| Fund Structure | Open-ended Investment Company (OEIC) |
| UCITS compliance | Yes |
| Administrator | BNY Mellon Fund Services (Ireland) Designated Activity Company |
| Investment Advisor | First Trust Advisors L.P. |
| Custodian Bank | The Bank of New York Mellon SA/NV, Dublin Branch |
| Revision Company | PwC |
| Fiscal Year End | 31 December |
| Swiss representative | Oligo Swiss Fund Services SA |
| Swiss paying agent | Banque Cantonale de Genève |
| Germany | 30% tax rebate |
| Switzerland | ESTV Reporting |
| Austria | Tax Reporting Fund |
| UK | UK Reporting |
| Italy | 26.0% |
| Indextype | Total return index |
| Swap counterparty | - |
| Collateral manager | |
| Securities lending | No |
| Securities lending counterparty |
| Airbnb | 2.41% |
| ResMed, Inc. | 2.32% |
| Copart | 2.30% |
| Amgen, Inc. | 2.26% |
| CME Group | 2.24% |
| Merck & Co., Inc. | 2.23% |
| Garmin | 2.19% |
| Automatic Data Processing | 2.16% |
| Vertex Pharmaceuticals | 2.16% |
| Expand Energy | 2.14% |
| United States | 93.83% |
| Switzerland | 4.04% |
| United Kingdom | 1.83% |
| Other | 0.30% |
| Finance | 23.37% |
| Consumer Non-Cyclicals | 18.77% |
| Industrials | 15.70% |
| Healthcare | 15.04% |
| Other | 27.12% |
| Broker | Rating | Execution fee | Account fee | |
|---|---|---|---|---|
| | 0.00 € | 0.00 € | View offer** | |
| | 0.00 € | 0.00 € | View offer* |
| YTD | +9.36% |
| 1 month | +3.03% |
| 3 months | +1.87% |
| 6 months | +6.29% |
| 1 year | +7.52% |
| 3 years | +24.53% |
| 5 years | +35.85% |
| Since inception (MAX) | +59.13% |
| 2025 | -6.21% |
| 2024 | +17.92% |
| 2023 | +4.39% |
| 2022 | -4.98% |
| Volatility 1 year | 11.61% |
| Volatility 3 years | 12.72% |
| Volatility 5 years | 14.56% |
| Return per risk 1 year | 0.65 |
| Return per risk 3 years | 0.60 |
| Return per risk 5 years | 0.43 |
| Maximum drawdown 1 year | -8.10% |
| Maximum drawdown 3 years | -15.91% |
| Maximum drawdown 5 years | -15.91% |
| Maximum drawdown since inception | -31.90% |
| Listing | Trade Currency | Ticker | Bloomberg / iNAV Bloomberg Code | Reuters RIC / iNAV Reuters | Market Maker |
|---|---|---|---|---|---|
| London Stock Exchange | GBP | - | |||
| London Stock Exchange | GBX | CAPS | CAPS LN | ||
| London Stock Exchange | USD | FTCS | FTCS LN |
| Fund name | Fund Size in m € (AuM) | TER p.a. | Distribution | Replication |
|---|---|---|---|---|
| iShares Edge MSCI USA Quality Factor UCITS ETF | 1,762 | 0.20% p.a. | Accumulating | Full replication |
| iShares Edge MSCI USA Quality Factor UCITS ETF USD (Dist) | 1,164 | 0.20% p.a. | Distributing | Full replication |
| UBS Factor MSCI USA Quality Screened UCITS ETF USD dis | 932 | 0.25% p.a. | Distributing | Full replication |
| WisdomTree US Quality Dividend Growth UCITS ETF USD Acc | 643 | 0.33% p.a. | Accumulating | Sampling |
| HSBC MSCI USA Quality UCITS ETF USD | 254 | 0.15% p.a. | Distributing | Full replication |